STS-1 promotes IFN-α induced autophagy by activating the JAK1-STAT1 signaling pathway in B cells

STS-1 promotes IFN-α induced autophagy by activating the JAK1-STAT1 signaling pathway in B cells
复制标题

STS-1通过激活B细胞中的JAK1-STAT1信号通路促进IFN-α诱导的自噬

DOI:
10.1002/eji.201445349
复制
发表时间:
2015-08-01
影响因子:
5.4
通讯作者:
Hou, Yayi
Hou, Yayi
中科院分区:
医学3区
文献类型:
--
作者:
Dong, Guanjun;You, Ming;Hou, Yayi

文献摘要

被引文献

相似文献

系统性红斑狼疮(SLE)是一种以ifn - α过表达为特征的自身免疫性疾病,ifn - α通过JAK1-STAT1信号通路诱导自噬,参与SLE的发病机制。最近的研究报道SLE患者和NZBM Fl小鼠的B细胞具有增强的自噬活性;然而,其机制尚不清楚。在这里,我们发现蛋白酪氨酸磷酸酶STS-1 (t细胞受体信号1的抑制因子)在SLE患者和MRL/Ipr小鼠的B细胞中显著过表达。值得注意的是,STS-1通过增强JAK1-STAT1信号通路激活,促进ifn - α诱导的B细胞自噬。STS-1抑制E3泛素蛋白连接酶c-cbl的磷酸化,随后促进ifn诱导的酪氨酸激酶2的磷酸化,导致JAK1-STAT1信号通路激活。此外,STAT1和JAK1抑制剂阻断了STS-1促进ifn - α诱导的自噬,表明STS-1通过JAK1-STAT1信号通路促进ifn - α诱导的自噬。我们的研究结果表明STS-1在调节ifn - α诱导的B细胞自噬中的重要性,这可以作为治疗SLE的一种治疗方法。
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the overexpression of IFN-alpha IFN-alpha induces autophagy via the JAK1-STAT1 signaling pathway, contributing to the pathogenesis of SLE. Recent studies reported that B cells from patients with SLE and NZBM Fl mice had enhanced autophagy activity; however, the mechanism still remains unknown. Here, we show that the protein tyrosine phosphatase STS-1 (suppressor of T-cell receptor signaling 1) was significantly overexpressed in B cells from patients with SLE and MRL/Ipr mice. Notably, STS-1 promoted IFN-alpha-induced autophagy in B cells by enhancing the JAK1-STAT1 signaling activation. STS-1 inhibited the phosphorylation of the E3 ubiquitin protein ligase c-cbl, and subsequently promoted IFN-ainduced phosphorylation of tyrosine kinase 2, leading to JAK1-STAT1 signaling activation. Furthermore, STAT1 and JAK1 inhibitors blocked the IFN-a-induced autophagy promoted by STS-1, indicating that STS-1 promotes IFN-alpha-induced autophagy via the JAK1-STAT1 signaling. Our results demonstrate the importance of STS-1 in regulating IFN-alpha-induced autophagy in B cells, and this could be used as a therapeutic approach to treat SLE.